The temporal stability of the Symptom Index among women at high-risk for ovarian cancer

Gynecologic Oncology

Volumn 114, Issue 2, 2009, Pages 225-230

  Lowe, Kimberly A ^a,b   Andersen, M Robyn ^a,c   Urban, Nicole ^a,c   Paley, Pamela ^a,d   Dresher, Charles W ^a,d   Goff, Barbara A ^d,e  

^a Fred Hutchinson Cancer Research Center   (United States)

^b Exponent Health Sciences   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d Pacific Gynecology Specialists   (United States)

^e SEATTLE CANCER CARE ALLIANCE   (United States)

Author keywords

Longitudinal analysis; Ovarian cancer; Symptom Index

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ABDOMEN; ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BLOATING; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; DISEASE ASSOCIATION; EATING DISORDER; FAMILY HISTORY; FEMALE; GENE MUTATION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; ONCOGENE; ORGAN SIZE; OVARY CANCER; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; RISK ASSESSMENT; SELF REPORT; SUPERIOR SAGITTAL SINUS; SYMPTOM;

ADULT; AGED; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; OVARIAN NEOPLASMS; PATIENT PARTICIPATION; SELF DISCLOSURE;

EID: 67549130166     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.03.015     Document Type: Article

References (19)

1. Holschneider C.H., and Berek J. Ovarian cancer: epidemiology, biology and prognostic factors. Semin. Surg. Oncol. 19 (2000) 3-10
2. Jemal A., Siegel R., Ward E., Murray T., Xu J., and Thun M.J. Cancer statistics, 2008. CA Cancer J. Clin. 58 (2008) 71-96
3. Ozols R.F., Rubin S.C., Thomas G.M., and Robboy S.J. Epithelial ovarian cancer. In: Hoskins W.J., Perez C.A., Young R., and Barakat R. (Eds). Principles and practice of gynecologic oncology. 4th ed (2005), Lippincott Williams & Wilkins, Philadelphia, PA 895-987
4. Goff B.A., Mandel L., Muntz H.G., and Melancon C.H. Ovarian carcinoma diagnosis: results of a national ovarian cancer survey. Cancer 89 (2000) 2068-2075
5. Goff B.A., Mandel L.S., Drescher C.W., Urban N., Gough S., Schurman K.M., et al. Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer 109 (2007) 221-227
6. Goff B.A., Mandel L.S., Melancon C.H., and Muntz H.G. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA 291 (2004) 2705-2712
7. Koldjeski D., Kirkpatrick M.K., Swanson M., Everett L., and Brown S. Ovarian cancer: early symptom patterns. Oncol. Nurs. Forum 30 (2003) 927-933
8. Lataifeh I., Marsden D.E., Robertson G., Gebski V., and Hacker N.F. Presenting symptoms of epithelial ovarian cancer. Aust. N. Z. J. Obstet. Gynaecol. 45 (2005) 211-214
9. Olson S.H., Mignone L., Nakraseive C., Caputo T.A., Barakat R.R., and Harlap S. Symptoms of ovarian cancer. Obstet. Gynecol. 98 (2001) 212-217
10. Ryerson A.B., Eheman C., Burton J., McCall N., Blackman D., Subramanian S., et al. Symptoms, diagnosis, and time to key diagnostic procedures among older U.S. women with ovarian cancer. Obstet. Gynecol. 109 (2007) 1053-1061
11. Vine M.F., Ness R.B., Calingaert B., Schildkraut J.M., and Berchuck A. Types and duration of symptoms prior to diagnosis of invasive or borderline ovarian tumor. Gynecol. Oncol. 83 (2001) 466-471
12. Wikborn C., Pettersson F., Silfversward C., and Moberg P.J. Symptoms and diagnostic difficulties in ovarian epithelial cancer. Int. J. Gynaecol. Obstet. 42 (1993) 261-264
13. Andersen M.R., Goff B.A., Lowe K.A., Scholler N., Bergan L., Drescher C.W., et al. Combining a symptoms index with CA 125 to improve detection of ovarian cancer. Cancer 113 (2008) 484-489
14. Urban N., McIntosh M.W., Andersen M., and Karlan B.Y. Ovarian cancer screening. Hematol. Oncol. Clin. North Am. 17 (2003) 989-1005 ix
15. Lowe K.A., Shah C., Wallace E., Anderson G., Paley P., McIntosh M., et al. Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer. Cancer Epidemiol. Biomark. Prev. 17 (2008) 2480-2487
16. Bankhead C.R., Kehoe S.T., and Austoker J. Symptoms associated with ovarian cancer : a systematic review. BJOG 112 (2005) 857-865
17. McIntosh M.W., and Urban N. A parametric empirical Bayes method for cancer screening using longitudinal observations of a biomarker. Biostatistics 4 (2003) 27-40
18. McIntosh M.W., Urban N., and Karlan B. Generating longitudinal screening algorithms using novel biomarkers for disease. Cancer Epidemiol. Biomark. Prev. 11 (2002) 159-166
19. Buys S.S., Partridge E., Greene M.H., Prorok P.C., Reding D., Riley T.L., et al. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial. Am. J. Obstet. Gynecol. 193 (2005) 1630-1639